Published in Int J Cancer on August 29, 2013
Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy. Oncotarget (2015) 0.97
Alternative splicing regulation of telomerase: a new paradigm? Trends Genet (2014) 0.90
Inflammatory microenvironment contributes to epithelial-mesenchymal transition in gastric cancer. World J Gastroenterol (2016) 0.78
SPARC Controls Melanoma Cell Plasticity through Rac1. PLoS One (2015) 0.76
Knockdown of Long Non-Coding RNA KCNQ1OT1 Restrained Glioma Cells' Malignancy by Activating miR-370/CCNE2 Axis. Front Cell Neurosci (2017) 0.75
Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege. Cancer Cell (2004) 2.46
Positron emission tomography imaging of adenoviral-mediated transgene expression in liver cancer patients. Gastroenterology (2005) 1.75
SPARC endogenous level, rather than fibroblast-produced SPARC or stroma reorganization induced by SPARC, is responsible for melanoma cell growth. J Invest Dermatol (2007) 1.51
Model based analysis of real-time PCR data from DNA binding dye protocols. BMC Bioinformatics (2007) 1.50
The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host. Cancer Metastasis Rev (2008) 1.45
Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors. J Clin Oncol (2004) 1.25
p21 differentially regulates DNA replication and DNA-repair-associated processes after UV irradiation. J Cell Sci (2008) 1.24
Ecophysiology of Antarctic vascular plants. Physiol Plant (2002) 1.14
Antitumor effects of hyaluronic acid inhibitor 4-methylumbelliferone in an orthotopic hepatocellular carcinoma model in mice. Glycobiology (2011) 1.11
RDAVIDWebService: a versatile R interface to DAVID. Bioinformatics (2013) 1.10
The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host. Cancer Metastasis Rev (2008) 1.10
Silencing survivin gene expression promotes apoptosis of human breast cancer cells through a caspase-independent pathway. J Cell Biochem (2008) 1.05
Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo. Mol Pharm (2011) 1.04
Dendritic cells delivered inside human carcinomas are sequestered by interleukin-8. Int J Cancer (2005) 1.01
Improving efficacy of interleukin-12-transfected dendritic cells injected into murine colon cancer with anti-CD137 monoclonal antibodies and alloantigens. Int J Cancer (2004) 1.00
Arabidopsis thaliana avoids freezing by supercooling. J Exp Bot (2006) 0.98
Single low-dose cyclophosphamide combined with interleukin-12 gene therapy is superior to a metronomic schedule in inducing immunity against colorectal carcinoma in mice. Oncoimmunology (2012) 0.96
Reversal of gastrointestinal carcinoma-induced immunosuppression and induction of antitumoural immunity by a combination of cyclophosphamide and gene transfer of IL-12. Mol Oncol (2011) 0.95
Description of Echinococcus granulosus genotypes in human hydatidosis in a region of southern Chile. Parasitol Int (2008) 0.95
Antitumor immunotherapeutic and toxic properties of an HDL-conjugated chimeric IL-15 fusion protein. Cancer Res (2012) 0.94
Secreted protein acidic and rich in cysteine produced by human melanoma cells modulates polymorphonuclear leukocyte recruitment and antitumor cytotoxic capacity. Cancer Res (2005) 0.94
Adenovirus-mediated inhibition of SPARC attenuates liver fibrosis in rats. J Gene Med (2008) 0.94
SPARC modulates the proliferation of stromal but not melanoma cells unless endogenous SPARC expression is downregulated. Int J Cancer (2008) 0.93
Prognostic factors of phyllodes tumor of the breast. Pathol Int (2006) 0.92
Immunotherapy for liver tumors: present status and future prospects. J Biomed Sci (2009) 0.92
Interleukin-15 in gene therapy of cancer. Curr Gene Ther (2013) 0.91
A tumor-stroma targeted oncolytic adenovirus replicated in human ovary cancer samples and inhibited growth of disseminated solid tumors in mice. Mol Ther (2012) 0.90
[Immunohistochemical expression of the E-cadherin-catenin complex in gastric cancer]. Rev Med Chil (2006) 0.89
SPARC downregulation attenuates the profibrogenic response of hepatic stellate cells induced by TGF-β1 and PDGF. Am J Physiol Gastrointest Liver Physiol (2011) 0.89
SPARC promotes cathepsin B-mediated melanoma invasiveness through a collagen I/α2β1 integrin axis. J Invest Dermatol (2011) 0.88
IL-12 and IL-10 expression synergize to induce the immune-mediated eradication of established colon and mammary tumors and lung metastasis. J Immunol (2005) 0.88
Overexpression of SPARC obliterates the in vivo tumorigenicity of human hepatocellular carcinoma cells. Int J Cancer (2010) 0.87
Microsatellite instability in preneoplastic and neoplastic lesions of the gallbladder. J Gastroenterol (2005) 0.87
Imbalance of antioxidant enzymes in tumor cells and inhibition of proliferation and malignant features by scavenging hydrogen peroxide. Mol Carcinog (2004) 0.87
Therapeutic improvement of a stroma-targeted CRAd by incorporating motives responsive to the melanoma microenvironment. J Invest Dermatol (2013) 0.87
The therapeutic potential of bone marrow-derived mesenchymal stromal cells on hepatocellular carcinoma. Liver Int (2013) 0.87
Potentiation of therapeutic immune responses against malignancies with monoclonal antibodies. Clin Cancer Res (2003) 0.86
[Promoter methylation profile in gastric cancer]. Rev Med Chil (2005) 0.86
Cytokine gene transfer for cancer therapy. Cytokine Growth Factor Rev (2007) 0.86
Tumor associated stromal cells play a critical role on the outcome of the oncolytic efficacy of conditionally replicative adenoviruses. PLoS One (2008) 0.85
A novel synergistic combination of cyclophosphamide and gene transfer of interleukin-12 eradicates colorectal carcinoma in mice. Clin Cancer Res (2009) 0.85
Gene therapy for autoimmune diseases: quo vadis? Nat Rev Immunol (2004) 0.85
Lack of the matricellular protein SPARC (secreted protein, acidic and rich in cysteine) attenuates liver fibrogenesis in mice. PLoS One (2013) 0.85
A specific subpopulation of mesenchymal stromal cell carriers overrides melanoma resistance to an oncolytic adenovirus. Stem Cells Dev (2012) 0.85
Mesenchymal Stem/Stromal Cells in Liver Fibrosis: Recent Findings, Old/New Caveats and Future Perspectives. Stem Cell Rev (2015) 0.84
Promoter methylation profile in gallbladder cancer. J Gastroenterol (2006) 0.84
Anti-ICAM-2 monoclonal antibody synergizes with intratumor gene transfer of interleukin-12 inhibiting activation-induced T-cell death. Clin Cancer Res (2003) 0.83
Mesenchymal stromal cells engineered to produce IGF-I by recombinant adenovirus ameliorate liver fibrosis in mice. Stem Cells Dev (2014) 0.83
Gene therapy of liver diseases. Expert Opin Biol Ther (2004) 0.83
Altered hyaluronan biosynthesis and cancer progression: an immunological perspective. Mini Rev Med Chem (2009) 0.83
Positron emission tomography and gene therapy: basic concepts and experimental approaches for in vivo gene expression imaging. Mol Imaging Biol (2004) 0.82
Anti-tumor effect of SLPI on mammary but not colon tumor growth. J Cell Physiol (2013) 0.82
Proteomic analysis identified N-cadherin, clusterin, and HSP27 as mediators of SPARC (secreted protein, acidic and rich in cysteines) activity in melanoma cells. Proteomics (2007) 0.82
Pulsing dendritic cells with whole tumor cell lysates. Methods Mol Biol (2014) 0.82
Suramab, a novel antiangiogenic agent, reduces tumor growth and corneal neovascularization. Cancer Chemother Pharmacol (2010) 0.82
A novel A33 promoter-based conditionally replicative adenovirus suppresses tumor growth and eradicates hepatic metastases in human colon cancer models. Clin Cancer Res (2009) 0.82
Daidzein-estrogen interaction in the rat uterus and its effect on human breast cancer cell growth. J Med Food (2012) 0.81
Suppression of cancer growth by nonviral gene therapy based on a novel reactive oxygen species-responsive promoter. Mol Ther (2009) 0.81
An anti-ICAM-2 (CD102) monoclonal antibody induces immune-mediated regressions of transplanted ICAM-2-negative colon carcinomas. Cancer Res (2002) 0.81
Amyloid peptides ABri and ADan show differential neurotoxicity in transgenic Drosophila models of familial British and Danish dementia. Mol Neurodegener (2014) 0.81
[Human papilloma virus (HPV) typing in preneoplastic and neoplastic lesions of the uterine cervix in the IX region-Chile]. Rev Med Chil (2003) 0.80
Dendritic cells regulate angiogenesis associated with liver fibrogenesis. Angiogenesis (2013) 0.80
Molecular characterization of a cDNA encoding Cu/Zn superoxide dismutase from Deschampsia antarctica and its expression regulated by cold and UV stresses. BMC Res Notes (2009) 0.80
Upregulation of natural killer cells functions underlies the efficacy of intratumorally injected dendritic cells engineered to produce interleukin-12. Exp Hematol (2002) 0.80
A novel hybrid promoter responsive to pathophysiological and pharmacological regulation. J Mol Med (Berl) (2011) 0.80
[K-ras gene mutation in gallbladder carcinoma]. Rev Med Chil (2004) 0.79
[Promoter methylation profile in breast cancer]. Rev Med Chil (2004) 0.79
[Microsatellite instability and loss of heterozygosity in neoplastic and preneoplastic gastric lesions]. Rev Med Chil (2003) 0.78
[Neoadjuvant chemoradiotherapy in gallbladder cancer]. Rev Med Chil (2004) 0.78
Double mutation in photosystem II reaction centers and elevated CO2 grant thermotolerance to mesophilic cyanobacterium. PLoS One (2011) 0.78
Low molecular weight hyaluronan preconditioning of tumor-pulsed dendritic cells increases their migratory ability and induces immunity against murine colorectal carcinoma. Cancer Immunol Immunother (2011) 0.78
Genistein selectively inhibits estrogen-induced cell proliferation and other responses to hormone stimulation in the prepubertal rat uterus. J Med Food (2011) 0.78
Intratumoural administration of dendritic cells: hostile environment and help by gene therapy. Expert Opin Biol Ther (2005) 0.77
HFE gene mutations in Chile. Ann Intern Med (2003) 0.77
The liver, liver metastasis and liver cancer: a special case for immunotherapy with cytokines and immunostimulatory monoclonal antibodies. Immunotherapy (2012) 0.77
[KRAS gene mutation in colorectal cancer]. Rev Med Chil (2013) 0.77
The multi-reference contrast method: facilitating set enrichment analysis. Comput Biol Med (2012) 0.76
[Detection of human papilloma virus in cytologic samples or biopsies of the cervix]. Rev Med Chil (2005) 0.76
Teneurin protein family: an emerging role in human tumorigenesis and drug resistance. Cancer Lett (2012) 0.76
Clinical implications of antigen transfer mechanisms from malignant to dendritic cells. exploiting cross-priming. Exp Hematol (2002) 0.76
[Genetic changes in chronic gastritis: study of microsatellite instability and loss of heterozygosity]. Rev Med Chil (2003) 0.76
Biologic therapy of liver tumors. Surg Clin North Am (2004) 0.76
Ex vivo loading of autologous dendritic cells with tumor antigens. Methods Mol Biol (2014) 0.76
[Inactivation of CDKN2A gene (p16) in gallbladder carcinoma]. Rev Med Chil (2004) 0.76
Enhanced CRAd activity using enhancer motifs driven by a nucleosome positioning sequence. Mol Ther (2013) 0.76
Platelet-endothelial cell adhesion molecule-1 (CD31) recycles and induces cell growth inhibition on human tumor cell lines. J Cell Biochem (2006) 0.76